Impact of Nigella sativa oil on glycemic control in alloxan-induced diabetic Wistar rats DOI Open Access

Onahinon Christian,

Sunday Adakole Ogli,

Nndunno Akwaras

и другие.

International Journal of Research in Medical Sciences, Год журнала: 2024, Номер 12(8), С. 2762 - 2766

Опубликована: Июль 31, 2024

Background: To effectively manage diabetes, it is crucial to achieve optimal glycemic control by ensuring that A1C levels remain below 7.0%. This study aimed investigate the impact of Nigella sativa oil (black seed oil, BSO) on in alloxan-induced diabetic Wistar rats. Methods: Forty (40) male rats weighing 200-250 gm were randomly allocated into eight (8) groups five (5) animals per group. Group 1 received normal saline as normoglycemic control, while 2 8 given alloxan monohydrate induce hyperglycemia, following method Osikwe et al. Following induction group saline, 3 200 mg/kg metformin, 4 glimepiride, 5 2.5 ml/kg BSO, 6 glimepiride and 7 metformin metformin. Results: The results showed BSO significantly reduced fast blood glucose compared (p<0.05), lowered glycosylated hemoglobin <7%, improved pancreatic beta cell function. Conclusions: Black reduces fasting glucose, exhibits synergism with improves beta-cell function

Язык: Английский

Effects of Black Seed (Nigella sativa L.) on Cardiometabolic Indices in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of RCTs DOI Creative Commons
Mehdi Karimi, Samira Pirzad, Seyed Morteza Pourfaraji

и другие.

Complementary Therapies in Medicine, Год журнала: 2025, Номер unknown, С. 103174 - 103174

Опубликована: Апрель 1, 2025

Black seed is known for its health benefits in traditional medicine. While recent studies suggest it may improve cardiometabolic health, impact on type 2 diabetes mellitus (T2DM) remains unclear. This study aims to meta-analysis randomized controlled trials (RCTs) assess the effects of black supplementation indices T2DM patients. Following PRISMA guidelines, a comprehensive database search was conducted up January 2025, and data were extracted from relevant RCTs. Mean differences (MD) standard deviations (SD) analyzed using random-effects model, heterogeneity assessed, publication bias evaluated. The pooled 16 RCTs showed that significantly reduced fasting blood glucose (FBG) (MD: -21.43mg/dL; p=0.005), hemoglobin A1c (HbA1c) -0.44; p=0.01), total cholesterol (TC) -18.80mg/dL; p=0.04) low-density lipoprotein (LDL) -19.53mg/dL; p=0.003). No significant observed 2-hour postprandial (2-hpp), insulin, homeostatic model assessment (HOMA), triglycerides (TG), high-density (HDL), aspartate aminotransferase (AST), alanine (ALT), creatinine, body weight, or mass index (BMI). Subgroup analyses revealed effectively FBG longer than 8 weeks; additionally, HbA1c, HOMA, LDL higher doses (>1g/day), shorter durations (≤8 weeks), use oil form. appears FBG, TC, levels patients with T2DM. However, no other metabolic parameters, including TG, liver enzymes, kidney function, weight. These findings be beneficial adjunct therapy glycemic lipid control but require further research confirm broader effects.

Язык: Английский

Процитировано

0

Impact of Nigella sativa oil on glycemic control in alloxan-induced diabetic Wistar rats DOI Open Access

Onahinon Christian,

Sunday Adakole Ogli,

Nndunno Akwaras

и другие.

International Journal of Research in Medical Sciences, Год журнала: 2024, Номер 12(8), С. 2762 - 2766

Опубликована: Июль 31, 2024

Background: To effectively manage diabetes, it is crucial to achieve optimal glycemic control by ensuring that A1C levels remain below 7.0%. This study aimed investigate the impact of Nigella sativa oil (black seed oil, BSO) on in alloxan-induced diabetic Wistar rats. Methods: Forty (40) male rats weighing 200-250 gm were randomly allocated into eight (8) groups five (5) animals per group. Group 1 received normal saline as normoglycemic control, while 2 8 given alloxan monohydrate induce hyperglycemia, following method Osikwe et al. Following induction group saline, 3 200 mg/kg metformin, 4 glimepiride, 5 2.5 ml/kg BSO, 6 glimepiride and 7 metformin metformin. Results: The results showed BSO significantly reduced fast blood glucose compared (p<0.05), lowered glycosylated hemoglobin <7%, improved pancreatic beta cell function. Conclusions: Black reduces fasting glucose, exhibits synergism with improves beta-cell function

Язык: Английский

Процитировано

0